Flexibility of Aromatic Residues in the Active-site Gorge of Acetylcholinesterase: X-ray Versus Molecular Dynamics

Overview

Journal Biophys J

Publisher Cell Press

Specialty Biophysics

Date 2008 May 27

PMID 18502801

Citations 37

Authors

Yechun Xu

Jacques-Philippe Colletier

Martin Weik

Hualiang Jiang

John Moult

Israel Silman

Joel L Sussman

Affiliations

Soon will be listed here.

Abstract

The high aromatic content of the deep and narrow active-site gorge of acetylcholinesterase (AChE) is a remarkable feature of this enzyme. Here, we analyze conformational flexibility of the side chains of the 14 conserved aromatic residues in the active-site gorge of Torpedo californica AChE based on the 47 three-dimensional crystal structures available for the native enzyme, and for its complexes and conjugates, and on a 20-ns molecular dynamics (MD) trajectory of the native enzyme. The degree of flexibility of these 14 aromatic side chains is diverse. Although the side-chain conformations of F330 and W279 are both very flexible, the side-chain conformations of F120, W233, W432, Y70, Y121, F288, F290 and F331 appear to be fixed. Residues located on, or adjacent to, the Omega-loop (C67-C94), namely W84, Y130, Y442, and Y334, display different flexibilities in the MD simulations and in the crystal structures. An important outcome of our study is that the majority of the side-chain conformations observed in the 47 Torpedo californica AChE crystal structures are faithfully reproduced by the MD simulation on the native enzyme. Thus, the protein can assume these conformations even in the absence of the ligand that permitted their experimental detection. These observations are pertinent to structure-based drug design.

Citing Articles

Enzyme Dynamics Determine the Potency and Selectivity of Inhibitors Targeting Disease-Transmitting Mosquitoes.

Kumari R, Lindgren C, Kumar R, Forsgren N, Andersson C, Ekstrom F ACS Infect Dis. 2024; 10(10):3664-3680.

PMID: 39291389 PMC: 11474975. DOI: 10.1021/acsinfecdis.4c00531.

Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell Viability.

Zunec S, Vadlja D, Ramic A, Zandona A, Marakovic N, Brekalo I Int J Mol Sci. 2024; 25(1).

PMID: 38203326 PMC: 10778980. DOI: 10.3390/ijms25010155.

Design of electron-donating group substituted 2-PAM analogs as antidotes for organophosphate insecticide poisoning.

Kongkaew N, Hengphasatporn K, Injongkol Y, Mee-Udorn P, Shi L, Mahalapbutr P RSC Adv. 2023; 13(46):32266-32275.

PMID: 37928857 PMC: 10620644. DOI: 10.1039/d3ra03087c.

Engineering gain-of-function mutants of a WW domain by dynamics and structural analysis.

Lu J, Rahman M, Kazan I, Halloran N, Bobkov A, Ozkan S Protein Sci. 2023; 32(9):e4759.

PMID: 37574787 PMC: 10464296. DOI: 10.1002/pro.4759.

Potential of Vitamin B6 Dioxime Analogues to Act as Cholinesterase Ligands.

Gaso Sokac D, Zandona A, Roca S, Vikic-Topic D, Lihtar G, Marakovic N Int J Mol Sci. 2022; 23(21).

PMID: 36362178 PMC: 9655973. DOI: 10.3390/ijms232113388.

References

Morel N, Bon S, Greenblatt H, Van Belle D, Wodak S, Sussman J . Effect of mutations within the peripheral anionic site on the stability of acetylcholinesterase. Mol Pharmacol. 1999; 55(6):982-92. DOI: 10.1124/mol.55.6.982. View

Van Belle D, De Maria L, Iurcu G, Wodak S . Pathways of ligand clearance in acetylcholinesterase by multiple copy sampling. J Mol Biol. 2000; 298(4):705-26. DOI: 10.1006/jmbi.2000.3698. View

Rydberg E, Brumshtein B, Greenblatt H, Wong D, Shaya D, Williams L . Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: Binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge. J Med Chem. 2006; 49(18):5491-500. DOI: 10.1021/jm060164b. View

Gilson M, Straatsma T, McCammon J, Ripoll D, Faerman C, Axelsen P . Open "back door" in a molecular dynamics simulation of acetylcholinesterase. Science. 1994; 263(5151):1276-8. DOI: 10.1126/science.8122110. View

Colletier J, Sanson B, Nachon F, Gabellieri E, Fattorusso C, Campiani G . Conformational flexibility in the peripheral site of Torpedo californica acetylcholinesterase revealed by the complex structure with a bifunctional inhibitor. J Am Chem Soc. 2006; 128(14):4526-7. DOI: 10.1021/ja058683b. View

Greenblatt H, Kryger G, Lewis T, Silman I, Sussman J . Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution. FEBS Lett. 1999; 463(3):321-6. DOI: 10.1016/s0014-5793(99)01637-3. View

Rosenberry T . Acetylcholinesterase. Adv Enzymol Relat Areas Mol Biol. 1975; 43:103-218. DOI: 10.1002/9780470122884.ch3. View

Botti S, Felder C, Lifson S, Sussman J, Silman I . A modular treatment of molecular traffic through the active site of cholinesterase. Biophys J. 1999; 77(5):2430-50. PMC: 1300520. DOI: 10.1016/S0006-3495(99)77080-3. View

Inestrosa N, Alvarez A, Perez C, Moreno R, Vicente M, Linker C . Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron. 1996; 16(4):881-91. DOI: 10.1016/s0896-6273(00)80108-7. View

10.

Bolognesi M, Banzi R, Bartolini M, Cavalli A, Tarozzi A, Andrisano V . Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease. J Med Chem. 2007; 50(20):4882-97. DOI: 10.1021/jm070559a. View

11.

Ekstrom F, Pang Y, Boman M, Artursson E, Akfur C, Borjegren S . Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates. Biochem Pharmacol. 2006; 72(5):597-607. DOI: 10.1016/j.bcp.2006.05.027. View

12.

Dooley A, Shindo N, Taggart B, Park J, Pang Y . From genome to drug lead: identification of a small-molecule inhibitor of the SARS virus. Bioorg Med Chem Lett. 2005; 16(4):830-3. PMC: 7119130. DOI: 10.1016/j.bmcl.2005.11.018. View

13.

Kronman C, Ordentlich A, Barak D, Velan B, Shafferman A . The "back door" hypothesis for product clearance in acetylcholinesterase challenged by site-directed mutagenesis. J Biol Chem. 1994; 269(45):27819-22. View

14.

Faerman C, Ripoll D, Bon S, Le Feuvre Y, Morel N, Massoulie J . Site-directed mutants designed to test back-door hypotheses of acetylcholinesterase function. FEBS Lett. 1996; 386(1):65-71. DOI: 10.1016/0014-5793(96)00374-2. View

15.

Bartolucci C, Perola E, Cellai L, BRUFANI M, Lamba D . "Back door" opening implied by the crystal structure of a carbamoylated acetylcholinesterase. Biochemistry. 1999; 38(18):5714-9. DOI: 10.1021/bi982723p. View

16.

Amadei A, Linssen A, Berendsen H . Essential dynamics of proteins. Proteins. 1993; 17(4):412-25. DOI: 10.1002/prot.340170408. View

17.

Harel M, Schalk I, Bouet F, Goeldner M, Hirth C, Axelsen P . Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci U S A. 1993; 90(19):9031-5. PMC: 47495. DOI: 10.1073/pnas.90.19.9031. View

18.

Lewis W, Green L, Grynszpan F, Radic Z, Carlier P, Taylor P . Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks. Angew Chem Int Ed Engl. 2002; 41(6):1053-7. DOI: 10.1002/1521-3773(20020315)41:6<1053::aid-anie1053>3.0.co;2-4. View

19.

Weik M, Ravelli R, Kryger G, McSweeney S, Raves M, Harel M . Specific chemical and structural damage to proteins produced by synchrotron radiation. Proc Natl Acad Sci U S A. 2000; 97(2):623-8. PMC: 15380. DOI: 10.1073/pnas.97.2.623. View

20.

Tai K, Shen T, Borjesson U, Philippopoulos M, McCammon J . Analysis of a 10-ns molecular dynamics simulation of mouse acetylcholinesterase. Biophys J. 2001; 81(2):715-24. PMC: 1301548. DOI: 10.1016/S0006-3495(01)75736-0. View